Khalid Abd-Elaziz

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Induced Pluripotent Stem Cells

Replacement Therapy

High Efficiency

Top Venues

Clinical drug investigation

British journal of clinical pharmacology

Cancer chemotherapy and pharmacology

European clinical respiratory journal

This page only lists publications with an associated author ORCID identifier.

Publications

Lan Gao, Anuradha Bhattacharyya, Brian Beers, Diksha Kaushik, Amy-Lee Bredlau, Allan Kristensen, Khalid Abd-Elaziz, Richard Grant, Lee Golden, Ronald Kong
Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first-in-human study. British journal of clinical pharmacology (2024)
Vassilios Aslanis, Khalid Abd-Elaziz, Robert J Slack, Anne Brinch, Lise Gravelle, Wayne Morley, De Phung, Kimberly Herman, Ian Holyer, Karen Killerup Poulsen, Peter Dogterom, Susan Tantawi, Fredrik R Zetterberg, Brian Jacoby, Hans Schambye, Bertil Lindmark
Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1). Cancer chemotherapy and pharmacology (2024)
Khalid Abd-Elaziz, Christine Voors-Pette, Kang-Ling Wang, Sandy Pan, Yisheng Lee, John Mao, Yuhua Li, Benjamin Chien, David Lau, Zuzana Diamant
First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects. Clinical drug investigation 41 (1) (2020)
Khalid Abd-Elaziz, Joanne N G Oude Elberink, Zuzana Diamant
Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer. European clinical respiratory journal 7 (1) (2020)